NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer

Figure 6

Pathway enrichment investigations of NAV3-related DEGs. (a) The numbers of genes enriched in each GO category. (b) KEGG pathways are analyzed, and the top 30 pathways are mapped.

(a)

(b)